Maximilian Diehn

Associate Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maximilian Diehn is an Associate Professor at Stanford University, USA. His research focuses on the efficacy and toxicity of radiation therapy, with recent articles exploring topics such as thoracic reirradiation, locoregional failure in glottic cancer, and the detection of tumor recurrence. He is also engaged in studies related to circulating tumor DNA and the immunologic responses in glioma treatment, contributing significantly to the fields of oncology and radiation medicine.

Articles (8)

Year:

2025

Year:

2025

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Aaron Newman

Assistant Professor

Stanford University

UNITED STATES

View details

Arash Ash Alizadeh

Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

Johannes Reiter

Assistant Professor

Stanford University

UNITED STATES

View details

Amato J. Giaccia

Stanford University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maximilian Diehn

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Efficacy and toxicity of hyperfractionated thoracic reirradiation

Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer

Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT

Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease

A mathematical model of ctDNA shedding predicts tumor detection size

Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma

Response Letter: Radiation therapy for COVID-19 pneumopathy

Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable

Collaborators (4)

Aaron Newman

Arash Ash Alizadeh

Johannes Reiter

Amato J. Giaccia

Make your next move.